Clinical Trial Update: Phase 1 Trial With SIR-Spheres and Cetuximab +/- Erlotinib [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating SIR-Spheres with cetuximab, with or without erlotinib, for advanced cancers has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• ERBITUX (cetuximab)
• SIR-Spheres (yttrium-90 glass microspheres)
• Tarceva (erlotinib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Cancers | Phase 1 | Status: WITHDRAWN